
|Articles|July 17, 2007
Update On Shelhigh/US Agreement
Shelhigh, Inc. has agreed to stop distributing its implantable medical devices, used in heart surgery and other procedures, until the company brings its production processes in line with Food and Drug Administration (FDA) standards [more].
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP updates guidance on pediatric iron deficiency screening and treatment
2
Pediatric clinical trial update: Q2 2026
3
FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis
4
FDA approves risankizumab for pediatric plaque psoriasis and psoriatic arthritis
5




